Medizone Intl. (fka MZEIQ)

[futurist7]

On Plan B… Medizone still holds an USPTO-issued patent, " Apparatus for the application of ozone/oxygen mixtures for the treatment of external pathogenic conditions" USPTO No. 6,073,627. It has about 5 years to go. Al that would have to be done is to revive this patent and announce a clinical study on the healing of diabetic skin ulcers in a Tier One country (One has already been done and the results are quite successful). The stock would soon climb to dollars. The promise for the healing of diabetic skin ulcers and the reduction of limb amputations is huge. We have 25 million diabetics in the US and 15% develop skin lesions. Wound healing was a 20 billion market in 2015.